Shop by goal
Metabolic Research
GH-Axis Research
Muscle & IGF Research
Tissue and Cellular Models
Regenerative Research
Cellular Senescence Research
Cognitive Research
Multi-Compound Blends
Accessories
All compounds →
Popular compounds
BPC-157
TB-500
GHK-Cu
GLP1-RC-RT
GLP1-RC-SM
Ipamorelin
All bestsellers →
Research resources
Research Glossary
Peptide Guides
Delivery Guide
Track Order
Recently viewed
Peptide 101
Research Areas
Peptide Blog
Community Forum
Crypto Blog
Research Glossary
Reconstitution Calculator
Peptide Tracker
Research Protocol Tools
Peptide Guides
Sign In
Create Account
Track My Order
Refer a Friend
My Account
My Orders
My Referrals
Log Out
How-to guides
Metabolic & GLP-1 research
The incretin and metabolic research area - GLP-1, GIP and glucagon receptor agonists studied in obesity and metabolic science.
Incretin research is one of the most active areas in modern metabolic science. GLP-1 receptor agonists - and the newer dual (GLP-1/GIP) and triple (GLP-1/GIP/glucagon) agonists - are studied for their effects on energy balance, insulin sensitivity and body-weight regulation in preclinical and clinical literature.
This hub groups the research compounds New-U supplies in this area alongside the on-site guides that summarise the published science.
All 5 compounds in this area have a current published Certificate of Analysis from an independent laboratory, linked on its card below and listed at /coa.
Research compounds in this area
Research reading
glp 1 rc comparison
retatrutide phase 3 trials triumph
is retatrutide safe
oral vs injectable glp1
cagrisema cagrilintide research guide
beyond glp 1 next obesity research wave
Explore Metabolic & GLP-1 research
Per-compound research guides, side-by-side comparisons and current analytical evidence for the compounds studied in this area. Research use only.
Research guide Retatrutide research guide Published experimental work characterises agonist activity across GLP-1R, GIPR and GCGR, with structural modifications investigated for… Read the guide →
Research guide Tirzepatide research guide Published experimental work characterises dual GIPR / GLP-1R agonist activity with imbalanced agonism, plus an albumin-binding structural… Read the guide →
Research guide Semaglutide research guide Published experimental work characterises GLP-1R agonist activity, with an albumin-binding structural modification investigated as a… Read the guide →
Research guide Cagrilintide research guide Cagrilintide activates all three amylin receptor subtypes plus the calcitonin receptor, modulating arcuate nucleus appetite neurons and… Read the guide →
Research guide Eloralintide research guide Eloralintide is a selective amylin receptor agonist that preferentially activates AMY1R to engage satiety circuits and reduce food intake -… Read the guide →
Compare Compare Retatrutide and Semaglutide Retatrutide vs Semaglutide: mechanism, receptor profile and specifications side by side. Compare →
Compare Compare Tirzepatide and Retatrutide Tirzepatide vs Retatrutide: mechanism, receptor profile and specifications side by side. Compare →
Compare Compare Tirzepatide and Semaglutide Tirzepatide vs Semaglutide: mechanism, receptor profile and specifications side by side. Compare →
Compare Compare Retatrutide and Liraglutide Retatrutide vs Liraglutide: mechanism, receptor profile and specifications side by side. Compare →
Related research Retatrutide Phase 3: The Triple-Hormone GLP-1 Story Retatrutide Phase 3 data was presented at the 2026 ADA Sessions. Here is a research-focused look at why triple-hormone agonists now lead… Read the article →
Related research Retatrutide Search Demand in the UK: The 2026 Surge, Explained UK search interest in retatrutide ("reta") has climbed from near-zero to a Google Trends Breakout term since 2023. What is driving the UK… Read the article →
Related research Retatrutide vs amycretin: triple agonist vs single-molecule amylin + GLP-1 A GIP/GLP-1/glucagon triple agonist against Novo Nordisk’s amylin + GLP-1 agonist, in injectable and oral form: what the early-phase and… Read the article →
Frequently asked questions
What are GLP-1 receptor agonists in a research context?
GLP-1 (glucagon-like peptide-1) receptor agonists are peptides that bind the GLP-1 receptor, a target studied in metabolic and obesity research for its role in glucose-dependent insulin secretion and energy balance. New-U supplies these compounds for laboratory research use only.
What is the difference between single, dual and triple agonists?
Single agonists (e.g. semaglutide) target the GLP-1 receptor; dual agonists add GIP-receptor activity; triple agonists (e.g. retatrutide) add glucagon-receptor activity. The multi-receptor compounds are a newer focus of published metabolic research.
How is purity verified?
Released batches are analysed by independent laboratories (Janoshik Analytical and Freedom Diagnostics) by RP-HPLC for purity and mass spectrometry for identity. Every released sale batch must pass independent verification before it is offered for sale. Published Certificates of Analysis are listed per compound at /coa. In this area, all 5 compounds have a current published certificate.
Scientific sources & further reading
GLP-1 receptor agonist - Wikipedia
Semaglutide - Wikipedia
Retatrutide - Wikipedia
Research use only - all claims made on this site are for testing and research use only. This page summarises published research context and does not constitute medical advice or dosing guidance.
PRECISION. PURITY. PERFORMANCE.
Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.
Shop
All research compounds
Price list
Where to buy peptides
Compare compounds
Compare vial sizes
Affiliate programme
Research
Peptide 101
Published COAs
Research areas
Research blog
How-to guides
Peptide guides
Research glossary
Support
Track your order
Contact us
Shipping & delivery
International shipping
FAQ
Community forum
Refund policy
Ways to Pay
Google Pay
Apple Pay
Venmo
Cryptocurrency
Crypto wallets
Cash App
Card payments
Bank transfer (SEPA)
Paying with crypto
Live crypto prices
Shop by goal
Metabolic Research
GH-Axis Research
Muscle & IGF Research
Tissue and Cellular Models
Regenerative Research
Cellular Senescence Research
Cognitive Research
Multi-Compound Blends
Accessories
Shop by compound
BPC-157
TB-500
GHK-Cu
Tesamorelin
Retatrutide
Semaglutide
Tirzepatide
CJC-1295 (without DAC)
All compounds →
Shop by region
United Kingdom
United States
Australia
Canada
Canada (FR)
Ireland
Northern Ireland
Malta
Germany
France
Spain
Italy
Netherlands
Portugal
Greece
Austria
Poland
Sweden
Finland
Denmark
Norway
Croatia
Slovakia
Slovenia
Estonia
Latvia
Lithuania
Czechia
Hungary
Romania
Bulgaria
Belgium
Belgium (FR)
Luxembourg
Deutsch
Ελληνικά
Español
Français
Italiano
Research use only - all claims made on this site are for testing and research use only. Purchasers must be 21 years of age or older.
All rights reserved. Copyright of New-U held with Hilxera Distribution Services LLC 2026.
Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.
Principal office: 1712 Pioneer Ave., Ste. 500, Cheyenne, WY 82001, USA
© 2026 New-U Research Compounds · new-u.io
Research use only — not for human consumption. All products are supplied strictly for laboratory research purposes.
© 2026 New-U Research Compounds · new-u.io — Copyright held with Hilxera Distribution Services LLC. All rights reserved.